PARP1 and malignant colon neoplasm: How to cite this article: Ozden, O. et al. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.